Literature DB >> 28096913

Rethinking lymph node metastasis and cytoreductive nephrectomy.

Michael Leveridge1.   

Abstract

Year:  2016        PMID： 28096913      PMCID： PMC5167594          DOI： 10.5489/cuaj.4252

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

1.  Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy.

Authors:  Boris Gershman; Daniel M Moreira; Stephen A Boorjian; Christine M Lohse; John C Cheville; Brian A Costello; Bradley C Leibovich; R Houston Thompson
Journal:  Eur Urol       Date:  2015-06-01       Impact factor: 20.096

2.  Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Authors:  Juan Barbastefano; Jorge A Garcia; Paul Elson; Laura S Wood; Brian R Lane; Robert Dreicer; Steven C Campbell; Brian I Rini
Journal:  BJU Int       Date:  2010-11       Impact factor: 5.588

3.  Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.

Authors:  Boris Gershman; R Houston Thompson; Daniel M Moreira; Stephen A Boorjian; Christine M Lohse; Brian A Costello; John C Cheville; Bradley C Leibovich
Journal:  J Urol       Date:  2016-09-20       Impact factor: 7.450

4.  Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Authors:  Daniel Y C Heng; J Connor Wells; Brian I Rini; Benoit Beuselinck; Jae-Lyun Lee; Jennifer J Knox; Georg A Bjarnason; Sumanta Kumar Pal; Christian K Kollmannsberger; Takeshi Yuasa; Sandy Srinivas; Frede Donskov; Aristotelis Bamias; Lori A Wood; D Scott Ernst; Neeraj Agarwal; Ulka N Vaishampayan; Sun Young Rha; Jenny J Kim; Toni K Choueiri
Journal:  Eur Urol       Date:  2014-06-13       Impact factor: 20.096

5.  Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed.

Authors:  Phillip M Pierorazio; James M McKiernan; Tara R McCann; Supriya Mohile; Daniel Petrylak; Mitchell C Benson
Journal:  BJU Int       Date:  2007-10       Impact factor: 5.588

6.  Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Authors:  Robert C Flanigan; G Mickisch; Richard Sylvester; Cathy Tangen; H Van Poppel; E David Crawford
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

7.  Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.

Authors:  Quoc-Dien Trinh; Shyam Sukumar; Jan Schmitges; Marco Bianchi; Maxine Sun; Shahrokh F Shariat; Jesse D Sammon; Claudio Jeldres; Kevin C Zorn; Paul Perrotte; Markus Graefen; Craig G Rogers; James O Peabody; Mani Menon; Pierre I Karakiewicz
Journal:  Ann Surg Oncol       Date:  2012-12-23       Impact factor: 5.344
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.